Related Experiment Videos
Late recurrence of Graves' disease
The British Journal of Clinical Practice
|February 1, 1989
Summary
Graves' disease recurrence was diagnosed in a patient after a remarkable 31-year disease-free interval following carbimazole treatment. This case highlights the potential for late-onset hypothyroidism after extended remission.
Area of Science:
- Endocrinology
- Internal Medicine
- Clinical Case Studies
Background:
- Graves' disease is an autoimmune disorder causing hyperthyroidism.
- Carbimazole is a common antithyroid medication used for Graves' disease treatment.
- Relapse of Graves' disease can occur after treatment, but late recurrences are uncommon.
Observation:
- A patient previously treated for Graves' disease with carbimazole presented with disease recurrence.
- The recurrence was diagnosed after a significant disease-free interval of 31 years.
- This represents a rare instance of very late-onset hypothyroidism after prolonged remission.
Findings:
- The patient experienced a recurrence of Graves' disease after 31 years of remission.
- This extended disease-free period challenges typical relapse timelines.
- The case underscores the importance of long-term patient monitoring.
Implications:
- This case suggests that patients treated for Graves' disease may require lifelong monitoring, even after decades of remission.
- Understanding the mechanisms behind late recurrences is crucial for refining treatment strategies.
- Further research into factors predicting late-onset hypothyroidism is warranted.